Cardiorenal syndrome: Clinical and echocardiographic aspects

Paola Alprecht-Quiroz1, Byron Zúñiga-Pineda2,3,4, Joffre J Lara-Terán3

  • 1Departamento de Medicina Interna, Hospital Luis Vernaza, Guayaquil.

Insights

Cardiorenal syndrome (CRS) involves heart and kidney dysfunction, impacting patients with chronic kidney disease. Early diagnosis and interventions, including echocardiography and renal transplantation, are key to managing this complex condition.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Cardiorenal syndrome (CRS) is characterized by acute or chronic dysfunction between the heart and kidneys.
  • Patients with end-stage chronic kidney disease (CKD) exhibit high cardiovascular morbimortality, particularly heart failure (HF).
  • Myocardial injury in CKD leads to ventricular remodeling and compensatory mechanisms involving renal regulation of fluid balance.

Purpose of the Study:

  • To outline diagnostic and therapeutic strategies for cardiorenal syndrome.
  • To highlight the role of echocardiography in diagnosing CRS.
  • To explore treatment options, including renal transplantation for cardiac dysfunction in CKD patients.

Main Methods:

  • Review of clinical phenotypes of CRS.
  • Analysis of cardiovascular and renal interactions in heart failure and atherosclerotic disease.
  • Evaluation of diagnostic tools, specifically echocardiography.
  • Assessment of therapeutic interventions, including renal transplantation.

Main Results:

  • CRS presents with distinct clinical phenotypes where dysfunction in one organ affects the other.
  • Hemodynamic interactions and atherosclerotic disease significantly impact both cardiac and renal systems in CKD patients.
  • Echocardiography is identified as a valuable diagnostic tool for CRS.

Conclusions:

  • Effective management of CRS requires understanding the interplay between cardiac and renal systems.
  • Timely diagnosis using tools like echocardiography is crucial.
  • Renal transplantation offers potential for remission of cardiac functional alterations in end-stage CKD patients.

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
156
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
354
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
616
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
207
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
457
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
673